Department of Radiology, CHU Lapeyronie, 371 Ave du Doyen Gaston Giraud, 34295 Montpellier, France.
AJR Am J Roentgenol. 2011 Oct;197(4):887-96. doi: 10.2214/AJR.10.6276.
The purpose of this study was to evaluate the diagnostic performance of CT in determining whether a small solid renal enhancing mass is benign or malignant.
Ninety-nine biopsies of enhancing solid renal masses 4 cm or smaller without fat on CT scans were performed under CT fluoroscopic guidance. The growth pattern, interface with parenchyma, presence of a scar and segmental inversion enhancement, unenhanced CT histogram, and pattern and degree of enhancement on triphasic MDCT images were independently evaluated by two radiologists. Biopsy and pathology reports were used as the reference standard, and imaging follow-up of benign lesions was performed for at least 1 year. Statistical analysis was performed to determine the significance of CT criteria in differentiating malignant from benign lesions.
Of the 99 lesions, 74 (75%) were malignant at biopsy, and 25 (25%) were benign. Lesions with gradual enhancement were more likely to be benign. No significant correlation was found between other CT features and a malignant or benign diagnosis. The sensitivity, specificity, and positive and negative predictive values of progressive enhancement for a diagnosis of benignity were 60%, 73%, 43%, and 84%.
In the evaluation of enhancing small solid renal lesions without fat, no CT criteria were of substantial help in differentiating malignant from benign lesions.
本研究旨在评估 CT 在确定小的实性肾脏强化肿块是良性还是恶性方面的诊断性能。
在 CT 透视引导下对 99 例直径≤4cm 的无脂肪增强实性肾脏肿块进行了活检。两位放射科医生分别对生长模式、与实质的界面、瘢痕和节段反转增强的存在、平扫 CT 直方图、三期 MDCT 图像的增强模式和程度进行了独立评估。以活检和病理报告为参考标准,对良性病变进行了至少 1 年的影像学随访。对 CT 标准在区分良恶性病变方面的意义进行了统计学分析。
99 例病变中,活检显示 74 例(75%)为恶性,25 例(25%)为良性。渐进性强化的病变更可能是良性的。其他 CT 特征与恶性或良性诊断之间没有显著相关性。渐进性强化对良性诊断的敏感度、特异度、阳性预测值和阴性预测值分别为 60%、73%、43%和 84%。
在评估无脂肪增强的小实性肾脏病变时,没有 CT 标准可以在区分良恶性病变方面提供实质性帮助。